Study finds dosing strategy may affect immunotherapy outcomes
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is
Read moreOverweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is
Read more